Medtech finds AI applications
Artificial intelligence is making its mark in medical technology applications.
Investing. Plain and simple.
Artificial intelligence is making its mark in medical technology applications.
Its 5th generation da Vinci robotic surgery tool has 10,000 times more processing power that generation 4.
Shipping costs and chip shortages have eased as demand for elective surgeries has recovered
Slowing growth in core businesses, plus recalls and bribery allegation have worried investors
Much delayed and needed elective surgeries are getting back on track as the latest wave of COVID-19 infections eases.
The healthcare sector offers safety and stability because the companies tend to perform well in all economic conditions.
Delayed surgeries are being rescheduled and more people are visiting their doctors.
Opinions differ on whether recovery will bring on a spending spree.
As global healthcare systems look for ways to cope with the COVID-19 pandemic, one place they are turning to is robots.
As robot-assisted surgeries grow, Stryker Corp. and Medtronic Inc.are gaining from investments in theses tools.







You must be logged in to post a comment.